Package 0904-6821-04

{"route": ["ORAL"], "spl_id": "cc508ae9-cfcb-48f7-b742-a0d3eec666b6", "openfda": {"unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["da78a5d3-f5c6-47fe-b593-3252704c225d"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0904-6821-04)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0904-6821-04", "marketing_start_date": "20180126"}], "brand_name": "tenofovir disoproxil fumarate", "product_id": "0904-6821_cc508ae9-cfcb-48f7-b742-a0d3eec666b6", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "0904-6821", "generic_name": "tenofovir disoproxil fumarate", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tenofovir disoproxil fumarate", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA203232", "marketing_category": "ANDA", "marketing_start_date": "20180126", "listing_expiration_date": "20261231"}